Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Drew Weissman

Showing results (191-200 of 293) with videos related to

Pageof 30
Sort By:
Biorxiv : the Preprint Server for Biology|May 10, 2023
Development of a nucleoside-modified mRNA vaccine against clade 2.3.4.4b H5 highly pathogenic avian influenza virusColleen Furey, Naiqing Ye, Lisa Kercher, et al.
Biorxiv : the Preprint Server for Biology|May 3, 2023
VEGFA mRNA-LNP promotes biliary epithelial cell-to-hepatocyte conversion in acute and chronic liver diseases and reverses steatosis and fibrosisFatima Rizvi, Yu-Ri Lee, Ricardo Diaz-Aragon, et al.
NPJ Vaccines|September 4, 2024
Broad protection and respiratory immunity of dual mRNA vaccination against SARS-CoV-2 variantsRenee L Hajnik, Jessica A Plante, Srinivasa Reddy Bonam, et al.
Communications Biology|February 22, 2023
Lipid nanoparticles (LNP) induce activation and maturation of antigen presenting cells in young and aged individualsJennifer Connors, David Joyner, Nathan J Mege, et al.
Communications Biology|February 22, 2025
Author Correction: Lipid nanoparticles (LNP) induce activation and maturation of antigen presenting cells in young and aged individualsJennifer Connors, David Joyner, Nathan J Mege, et al.
Nature Communications|March 5, 2025
Monitoring mRNA vaccine antigen expression in vivo using PET/CTGabrielle S Blizard, Garima Dwivedi, Yi-Gen Pan, et al.
The Journal of Clinical Investigation|September 23, 2025
Allergen-specific mRNA-lipid nanoparticle therapy for prevention and treatment of experimental allergy in miceYrina Rochman, Michael Kotliar, Andrea M Klingler, et al.
Nature Biomedical Engineering|November 23, 2024
Optimization of the activity and biodegradability of ionizable lipids for mRNA delivery via directed chemical evolutionXuexiang Han, Mohamad-Gabriel Alameh, Ying Xu, et al.
Science (New York, N.Y.)|July 27, 2023
In vivo hematopoietic stem cell modification by mRNA deliveryLaura Breda, Tyler E Papp, Michael P Triebwasser, et al.
Biorxiv : the Preprint Server for Biology|February 3, 2025
The type I IFN-IL-27 axis promotes mRNA vaccine-induced CD8 <sup>+</sup> T cell responsesAnthony T Phan, Emily Aunins, Elisa Cruz-Morales, et al.
Pageof 30

Showing results (191-200 of 293) with videos related to

Sort By:
Pageof 30
Biorxiv : the Preprint Server for Biology|May 10, 2023
Development of a nucleoside-modified mRNA vaccine against clade 2.3.4.4b H5 highly pathogenic avian influenza virusColleen Furey, Naiqing Ye, Lisa Kercher, et al.
Biorxiv : the Preprint Server for Biology|May 3, 2023
VEGFA mRNA-LNP promotes biliary epithelial cell-to-hepatocyte conversion in acute and chronic liver diseases and reverses steatosis and fibrosisFatima Rizvi, Yu-Ri Lee, Ricardo Diaz-Aragon, et al.
NPJ Vaccines|September 4, 2024
Broad protection and respiratory immunity of dual mRNA vaccination against SARS-CoV-2 variantsRenee L Hajnik, Jessica A Plante, Srinivasa Reddy Bonam, et al.
Communications Biology|February 22, 2023
Lipid nanoparticles (LNP) induce activation and maturation of antigen presenting cells in young and aged individualsJennifer Connors, David Joyner, Nathan J Mege, et al.
Communications Biology|February 22, 2025
Author Correction: Lipid nanoparticles (LNP) induce activation and maturation of antigen presenting cells in young and aged individualsJennifer Connors, David Joyner, Nathan J Mege, et al.
Nature Communications|March 5, 2025
Monitoring mRNA vaccine antigen expression in vivo using PET/CTGabrielle S Blizard, Garima Dwivedi, Yi-Gen Pan, et al.
The Journal of Clinical Investigation|September 23, 2025
Allergen-specific mRNA-lipid nanoparticle therapy for prevention and treatment of experimental allergy in miceYrina Rochman, Michael Kotliar, Andrea M Klingler, et al.
Nature Biomedical Engineering|November 23, 2024
Optimization of the activity and biodegradability of ionizable lipids for mRNA delivery via directed chemical evolutionXuexiang Han, Mohamad-Gabriel Alameh, Ying Xu, et al.
Science (New York, N.Y.)|July 27, 2023
In vivo hematopoietic stem cell modification by mRNA deliveryLaura Breda, Tyler E Papp, Michael P Triebwasser, et al.
Biorxiv : the Preprint Server for Biology|February 3, 2025
The type I IFN-IL-27 axis promotes mRNA vaccine-induced CD8 <sup>+</sup> T cell responsesAnthony T Phan, Emily Aunins, Elisa Cruz-Morales, et al.
Pageof 30